Waystar Holding Corp.

WAY

Held by 1 specialist biotech fund

Share on X

Fund Holdings

RA Capital Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

RA Capital ManagementNEWFeb 17, 2026

Shares: 144,400Value: $4.7M

**Signal Note: RA Capital Initiates Waystar Position** RA Capital's $4.7M entry into Waystar (healthcare IT/RCM platform) represents a notable shift toward healthcare infrastructure rather than therapeutics, suggesting conviction in operational efficiency plays within the broader healthcare system. The timing aligns with ongoing consolidation in healthcare revenue cycle management and potential margin expansion as providers optimize administrative workflows post-pandemic.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

SLDB1 fund SION1 fund SPRY1 fund ABOS1 fund TSHA1 fund PCSC1 fund RNA1 fund QGEN

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: